Western Financial Corp’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.34M Buy
2,020
+1,507
+294% +$1.78M 0.78% 31
2026
Q2
$615K Sell
513
-3,656
-88% -$3.74M 0.18% 90
2026
Q1
$3.83M Buy
4,169
+1,023
+33% +$1.04M 1.5% 14
2025
Q4
$3.38M Buy
+3,146
New +$3.01M 1.34% 15
2025
Q3
– Sell
-311
Closed -$242K – 126
2025
Q2
$242K Sell
311
-1,072
-78% -$833K 0.13% 115
2025
Q1
$1.14M Sell
1,383
-916
-40% -$762K 0.66% 39
2024
Q4
$1.77M Sell
2,299
-1,610
-41% -$1.33M 0.98% 24
2024
Q3
$3.46M Buy
3,909
+34
+0.9% +$30.6K 1.97% 6
2024
Q2
$3.51M Sell
3,875
-87
-2% -$69.6K 2.12% 6
2024
Q1
$3.08M Buy
3,962
+1,274
+47% +$907K 1.89% 7
2023
Q4
$1.57M Sell
2,688
-92
-3% -$53.7K 1.05% 14
2023
Q3
$1.49M Sell
2,780
-345
-11% -$178K 1.09% 11
2023
Q2
$1.47M Sell
3,125
-592
-16% -$248K 1% 13
2023
Q1
$1.28M Buy
3,717
+231
+7% +$77.9K 0.91% 19
2022
Q4
$1.28M Buy
3,486
+180
+5% +$63.8K 0.83% 18
2022
Q3
$1.07M Buy
3,306
+285
+9% +$90.3K 0.75% 24
2022
Q2
$979K Buy
+3,021
New +$907K 0.7% 27

Other funds holding LLY

Western Financial Corp's LLY Position: Q3 2026 in Review

Western Financial Corp increased its Eli Lilly (LLY) stake by 294% in Q3 2026, buying an estimated $1.78M and bringing the position to 2,020 shares worth $2.34M. The position accounts for 0.78% of the portfolio, ranked #31.

Western Financial Corp first reported a position in LLY in Q2 2022 and has held it in 17 quarters since. The position peaked at $3.83M in Q1 2026. 3,780 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Western Financial Corp held 2,020 shares of Eli Lilly worth $2.34M as of Q3 2026.
  • Western Financial Corp bought 1,507 Eli Lilly shares in Q3 2026, an estimated $1.78M.
  • Eli Lilly made up 0.78% of Western Financial Corp's portfolio in Q3 2026, its #31 holding.
  • Western Financial Corp first reported a position in Eli Lilly in Q2 2022 and has held it in 17 quarters since.
  • Western Financial Corp's Eli Lilly position peaked at $3.83M in Q1 2026.
  • 3,780 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Western Financial Corp's 13F filing for Q3 2026, filed 14 Oct 2026.